Abstract
The two serum proteins of the complement cascade in the highest concentrations, C3 and C4, respond to various conditions in much the same manner as do other positive acute‐phase proteins. A major difference is that they are relatively sluggish in response to cytokine drive, requiring several days rather than hours to be detectably elevated by serial measurements. As with other acute‐phase proteins, there are many processes that up‐ or down‐regulate synthesis, including infection or inflammation, hepatic failure, and immune‐complex formation. Clinicians may find it difficult to distinguish among these processes, because they often occur simultaneously. The situation is further complicated by genetic polymorphism, with rare instances of markedly reduced synthesis and circulating levels, and consequent vulnerability to infection. C3 and C4 are measured for clinical purposes to help define certain rheumatic and immunologically mediated renal diseases. Interpreting the measured blood levels of these two components requires one to consider the intensity of the inflammatory drive, the timing of the suspected clinical process, the production of complement‐consuming immune complexes, and the possible existence of benign circumstances. In this fifth article in a series, reference ranges for serum levels of two complement proteins (C3 and C4) are examined. The study is based on a cohort of over 55,000 Caucasian individuals from northern New England, who were tested in our laboratory in 1994–1999. Measurements were standardized against certified reference material (CRM) 470/reference preparation for proteins in human serum (RPPHS), and analyzed using a previously described statistical approach. Individuals with unequivocal laboratory evidence of inflammation (C‐reactive protein of 10 mg/L or higher) were excluded. Our results show that the levels of C3 and C4 change little during life and between the sexes, except that they increase slightly and then fall after age 20 in males and at about age 45 in females. When values were expressed as multiples of the age‐ and gender‐specific median levels, the resulting distributions fitted a log‐Gaussian distribution well over a broad range. When patient data are normalized in this manner, the distribution parameters can be used to assign a centile corresponding to an individual's measurement, thus simplifying interpretation. J. Clin. Lab. Anal. 18:1–8, 2004. © 2004 Wiley‐Liss, Inc.
Keywords: acute‐phase proteins, reference range, Caucasian, complement, C3, C4, CRM 470/RPPHS
REFERENCES
- 1. Haram K, Augensen K, Elsayed S. Serum protein in normal pregnancy with special reference to acute‐phase reactants. Br J Obstet Gynaecol 1983;90:139–145. [DOI] [PubMed] [Google Scholar]
- 2. Giacoia GP. Concentration of serum prealbumin and retinol‐binding proteins during pregnancy. South Med J 1984;77:1261–1263. [DOI] [PubMed] [Google Scholar]
- 3. Whicher J. Complement component C3 In: Ritchie RF, Navolotskaia O, editors. Serum proteins in clinical medicine. Vol. I Laboratory section, Foundation for Blood Research, Scarborough; 1996. Chapter 10.01, p 1–7. [Google Scholar]
- 4. Song CS, Merkatz IR, Rifking AB, Gillette PN, Kappas A. The influence of pregnancy and oral contraceptive steroids on the concentration of plasma proteins. Am J Obstet Gynecol 1970;108:227–231. [DOI] [PubMed] [Google Scholar]
- 5. Dotchev D, Liappis N, Hingerland H. Sex‐specific differences of serum proteins in adults and influence of oral hormonal contraceptives on serum protein compositions. Clin Chim Acta 1973;44:431–435. [DOI] [PubMed] [Google Scholar]
- 6. Navolotskaia O. Pregnancy/hormone effect In: Ritchie RF, Navolotskaia O, editors. Serum proteins in clinical medicine. Vol. II Clinical section, Foundation for Blood Research; 1999. p 106.0:1–11. [Google Scholar]
- 7. Alper CA, Colten HR, Gear JS, Rabson AR, Rosen FS. Homozygous human C3 deficiency. The role of C3 in antibody production, C‐1s‐induced vasopermeability, and cobra venom‐induced passive hemolysis. J Clin Invest 1976;57:222–229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Whicher JT, Ritchie RF, Johnson AM, et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994;40:934–938. [PubMed] [Google Scholar]
- 9. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for immunoglobulins A, G and M: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1998;12:363–370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for the negative acute phase proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Lab Clin Anal 1999;13:273–279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for the positive acute phase proteins, α1‐acid glycoprotein (orosomucoid), α1‐antitrypsin, and haptoglobin: a practical, simple, and clinically relevant approach to a large cohort. J Clin Lab Anal 2000;14:284–292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Ritchie RF, Palomaki GE, Navolotskaia O, Neveux LM, Ledue TB, Craig WY. Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal 2002;16:237–245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Ritchie RF, Palomaki GE, Navolotskaia O, Neveux LM, Ledue TB, Craig WY. Reference distributions for complement proteins C3 and C4: a comparison of a large cohort to the world's literature. J Lab Clin Anal 2004;18:9–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Healy MJR. Outliers in clinical chemistry quality‐control schemes. Clin Chem 1979;25:675–677. [PubMed] [Google Scholar]
- 15. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973–979. [DOI] [PubMed] [Google Scholar]
- 16. Joyce PR, Hawes CR, Mulder RT, Sellmen JD, Wilson DA, Boswell DR. Elevated levels of acute phase proteins in major depression. Biol Psychiatry 1992;32:1035–1041. [DOI] [PubMed] [Google Scholar]
- 17. Thompson DK, Haddow JE, Smith DE, Ritchie RF. Serum protein changes in women with early breast cancer. Cancer 1981;48:793–798. [DOI] [PubMed] [Google Scholar]
- 18. Maes M, Wauters A, Neels H, et al. Total serum protein and serum protein fractions in depression: relationship to depressive symptoms and glucocorticoid activity. J Affect Disord 1995;34:61–69. [DOI] [PubMed] [Google Scholar]
- 19. Ledue TB, Johnson MJ, Cohen LA, Ritchie RF. Evaluation of proficiency survey results for serum immunoglobulins following the introduction of a new international reference material for human serum proteins. Clin Chem 1998;44:878–879. [PubMed] [Google Scholar]
- 20. Ramcharan S, Sponzilli EE, Wingard JC. Serum protein fractions. Effects of oral contraceptives and pregnancy. Obstet Gynecol 1976;48:211–215. [PubMed] [Google Scholar]
- 21. Gardinali M, Conciato L, Cafaro C, et al. Complement system is not activated in primary biliary cirrhosis. Clin Immunol Immunopathol 1998;87:297–303. [DOI] [PubMed] [Google Scholar]
- 22. Ohshio G, Furakawa F, Manabe T, Tobe T, Hamashima Y. Relationship between secretory IgA, IgA‐containing (C3‐fixing) circulating immune complexes, and complement components (C3, C4) in patients with obstructive jaundice. Scand J Gastroenterol 1986;21:151–157. [DOI] [PubMed] [Google Scholar]
- 23. Sopena B, Martinez‐Vazquez C, de la Fuente J, et al. Serum levels of immunoglobulins and complement in alcoholic liver disease. Rev Clin Esp 1993;193:419–423. [PubMed] [Google Scholar]
- 24. Schlesinger M, Benbassat C, Schoefeld Y. Complement profile in primary biliary cirrhosis. Immunol Res 1992;11:98–103. [DOI] [PubMed] [Google Scholar]
- 25. Munoz LE, De Villiers D, Markham D, Whaley K, Thomas HC. Complement activation in chronic liver disease. Clin Exp Immunol 1982;47:548–554. [PMC free article] [PubMed] [Google Scholar]
- 26. Lamprecht P, Moosig F, Gause A, et al. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinemic vasculitis. Ann Rheum Dis 2001;60:385–390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. National Committee for Clinical Laboratory Standards . How to define and determine reference intervals in the clinical laboratory. Approved guideline. NCCLS document C28‐A. Villanova, PA: NCCLS; 1995.
- 28. Gräsbeck R, Siest G, Wilding P, Williams GZ, Whitehead TP. Provisional recommendation on the theory of reference values. Part 1. The concept of reference values. Clin Chim Acta 1978;87:461F–465F. [PubMed] [Google Scholar]